Acuta Capital Partners’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-17,500
| Closed | -$1.76M | – | 57 |
|
|
2021
Q3 | $1.76M | Buy |
17,500
+7,500
| +75% | +$755K | 0.62% | 34 |
|
|
2021
Q2 | $1.42M | Sell |
10,000
-4,000
| -29% | -$566K | 0.57% | 34 |
|
|
2021
Q1 | $1.4M | Buy |
+14,000
| New | +$1.4M | 0.5% | 41 |
|
|
2020
Q3 | – | Sell |
-15,300
| Closed | -$2.39M | – | 57 |
|
|
2020
Q2 | $2.39M | Sell |
15,300
-8,200
| -35% | -$1.28M | 0.69% | 39 |
|
|
2020
Q1 | $3.39M | Sell |
23,500
-14,500
| -38% | -$2.09M | 1.64% | 21 |
|
|
2019
Q4 | $7.77M | Sell |
38,000
-7,000
| -16% | -$1.43M | 1.92% | 17 |
|
|
2019
Q3 | $3.61M | Buy |
+45,000
| New | +$3.61M | 2.61% | 13 |
|